Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  sargramostim
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 493 for your search:
Start Over
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UARK 2003-26, NCT00090493
Phase III Randomized Study of PIXY321 vs GM-CSF for Mobilization of Hematopoietic Progenitors in Women with Metastatic Breast Carcinoma (Summary Last Modified 03/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
Phase III Randomized Study of Rescue with CD34+ Selected vs Unselected Autologous PBSC Following High-Dose BU/CTX for Multiple Myeloma (Summary Last Modified 03/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0060-002, NCI-V95-0712
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065658, S9704, U10CA032102, SWOG-S9704, CAN-NCIC-LY11, CALGB-59903, ECOG-S9704, LY11, NCT00004031
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: D9803, NCI-2012-02302, IRS-D9803, COG-D9803, POG-D9803, CDR0000067157, CCG-D9803, U10CA098543, NCT00003958
Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067568, U10CA021115, ECOG-4697, SWOG-E4697, E4697, NCT00005034
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-9901, CDR0000068406, NCI-P00-0177, NCT00008398
Phase III VMCP plus VBAP for Previously Untreated Stage I/II/III Multiple Myeloma with Hemi-body Radiotherapy plus VCR/PRED vs VMCP for Responders
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8229/30, SWOG-8230
A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 45 to 60
Sponsor: Other
Protocol IDs: EORTC-06864, NCT01324063
Phase III Randomized Double-Blind Placebo-Controlled Evaluation of Recombinant GM-CSF in Patients Undergoing Autologous or Syngeneic Bone Marrow Therapy (Summary Last Modified 02/89)
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15 to less than 65
Sponsor:
Protocol IDs: MSKCC-88108, NCI-V88-0644
Phase III Randomized Double-Blind Placebo-Controlled Evaluation of Recombinant GM-CSF in Patients Undergoing Autologous or Syngeneic Bone Marrow Therapy (Summary Last Modified 12/89)
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15 to less than 65
Sponsor:
Protocol IDs: GUMC-14088, NCI-V89-0065
Start Over